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ABSTRACT
Selenium,anessentialtraceelement,isincorporated
into selenoproteins as selenocysteine (Sec), the 21st
amino acid. In order to synthesize selenoproteins, a
translational reprogramming event must occur since
Sec is encoded by the UGA stop codon. In mammals,
the recoding of UGA as Sec depends on the
selenocysteine insertion sequence (SECIS) element,
a stem-loop structure in the 30 untranslated region of
the transcript. The SECIS acts as a platform for
RNA-binding proteins, which mediate or regulate
the recoding mechanism. Using UV crosslinking,
we identified a 110kDa protein, which binds with
high affinity to SECIS elements from a subset of
selenoprotein mRNAs. The crosslinking activity was
purified by RNA affinity chromatography and
identified as nucleolin by mass spectrometry
analysis. In vitro binding assays showed that
purified nucleolin discriminates among SECIS
elements in the absence of other factors. Based on
siRNA experiments, nucleolin is required for the
optimal expression of certain selenoproteins. There
was a good correlation between the affinity of
nucleolin for a SECIS and its effect on selenoprotein
expression. As selenoprotein transcript levels and
localization did not change in siRNA-treated cells,
our results suggest that nucleolin selectively
enhances the expression of a subset of seleno-
proteins at the translational level.
INTRODUCTION
Selenoproteins are a small but important subclass of
proteins that contain the essential trace element
selenium. The mammalian selenoproteins with known
functions perform a variety of critical roles in anti-oxidant
defense, thyroid hormone metabolism, male reproduction
and development (1). Selenium is co-translationally
incorporated into selenoproteins as selenocysteine (Sec),
the 21st amino acid. The translation of selenoprotein
mRNAs is complicated by the fact that Sec is encoded
by the UGA codon, which typically signals the termin-
ation of protein synthesis. However, UGA will be
recoded as Sec when the 30 untranslated region (30UTR)
of the transcript contains a speciﬁc stem-loop structure
called the Sec insertion sequence (SECIS) element (2).
All eukaryotic SECIS elements form a similar structure
composed of an apical loop and two stems separated by
an internal loop. Although SECIS elements share little
homology at the nucleotide level, they contain two
highly conserved motifs, which are essential for recoding
UGA as Sec. The SECIS core encompasses two sheared
tandem G A base pairs (3,4). The other essential sequence
is the AAPurine (AAR) motif, which is found either in
the apical loop (Type 1 SECIS) or adenosine bulge
(Type 2 SECIS) (5,6). Sec incorporation also requires a
novel Sec-charged tRNA, which has a UCA anticodon (7).
The synthesis and utilization of the Sec-tRNA
Sec requires
several proteins, including a specialized elongation factor,
EFsec, which is dedicated to Sec incorporation (8,9). Our
group puriﬁed and cloned two other trans-acting factors in
this pathway: SECIS binding protein 2 (SBP2) and ribo-
somal protein L30 (10,11). In vitro studies support the
hypothesis that SBP2 and L30 compete for binding to
the SECIS core and that the two proteins act sequentially
during UGA recoding (10). However, there is debate in
the ﬁeld regarding the speciﬁc functions of SBP2 and L30,
as well as the exact sequence of events that occur during
Sec incorporation (12,13).
Although dramatic progress has been made in
elucidating the mechanism of Sec incorporation, less is
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Selenoprotein synthesis is regulated by dietary selenium
invivo, but the eﬀects vary between tissues and between
individual selenoproteins. When selenium is limiting, the
element is preferentially retained and utilized by the brain
and endocrine organs at the expense of other tissues (14).
There is also a hierarchy of expression of individual
selenoproteins during selenium deﬁciency. For example,
the synthesis of phospholipid hydroperoxide glutathione
peroxidase (PHGPx or GPx4) is maintained, whereas the
expression of glutathione peroxidase 1 (GPx1) is rapidly
lost when selenium becomes limiting (15–17). Given that
SBP2 and L30 have both been shown to be limiting factors
for Sec incorporation, there may even be a hierarchy of
selenoprotein expression under selenium-adequate condi-
tions. Based on gene targeting studies in mice, certain
selenoproteins, including PHGPx, are required for
normal development and health (18,19), whereas others,
such as GPx1, appear to have redundant or secondary
functions (20,21). Thus, the limiting UGA recoding ma-
chinery may be preferentially recruited to a subset of tran-
scripts, which encode selenoproteins that perform critical
functions.
To the best of our knowledge, the 25 mammalian
selenoproteins all depend on the same set of trans-acting
factors for their synthesis. What is not well understood is
how the cell prioritizes the utilization of these factors.
SBP2 may dictate the expression pattern of the
selenoproteome since it is an essential factor for Sec in-
corporation and binds various SECIS elements with dif-
ferent aﬃnities invitro and invivo (22,23). However, the
complex hierarchy of selenoprotein expression is likely
to be maintained by the interplay between multiple
trans-acting factors that bind to cis-acting sequences in
the SECIS element and prioritize the utilization of
selenium in a tissue-speciﬁc and selenoprotein-dependent
manner. One such protein that links selenium status with
diﬀerential selenoprotein expression is eukaryotic initi-
ation factor 4a isoform 3 (eIF4a3). We recently showed
that eIF4a3 is a selenium-regulated SECIS-binding
protein that interacts selectively with a subset of
selenoprotein mRNAs, including GPx1 (24). Invitro and
cell culture studies support a model in which eIF4a3 trans-
lationally represses the expression of GPx1 by preventing
the binding of SBP2 to the SECIS, thus inhibiting Sec
incorporation (24).
In this study, we show that nucleolin selectively binds to
SECIS elements from a subset of selenoprotein mRNAs,
including PHGPx but not GPx1. Our studies support a
model in which nucleolin acts as a positive regulator of
selenoprotein mRNA translation.
MATERIALS AND METHODS
Cloning and mutagenesis
Information on the size and sequences of the SECIS
elements and irrelevant RNAs is provided in
Supplementary Table S1. The rat PHGPx and GPx1
30UTRs are previously described (25). The rat Sel15
(BC060547) 30UTR (1019–1217 nt) was cloned into the
EcoRI–HindIII sites of pGEM3zf0(+) plasmid. The
30UTRs of mouse GPx2 (BC039658), SelO (AK005048),
SelR (AF195142), SelW (BC052719) and the long TR1
(AB027565) were prepared as PCR products containing
a T7 promoter and were generous gifts of Heiko Mix
and Vadim Gladyshev (University of Nebraska). The
short TR1 SECIS of 207 nt was prepared as a PCR
product containing a T7 promoter. The SBP2 constructs
that encompass regions 1 and 2 correspond to 394–535
and 1–100 nt of the SBP2 30 UTR and are described in
ref. (26). The hypoxia stability region (HSR) from the
human VEGF-A 30 UTR (27) was a generous gift from
Peng Yao and Paul Fox. The PHGPx SECIS basal stem
deletion mutants are described in ref. (28). Additional mu-
tations in the PHGPx SECIS were made using the primers
listed in Supplementary Table S2 and the QuikChange
Site-Directed Mutagenesis Kit (Stratagene). All mutations
were conﬁrmed by DNA sequencing.
Invitro transcription
32P-labeled wild-type and mutant PHGPx SECIS probes
were prepared from linearized templates with T7 RNA
polymerase using 10mM GTP, 10mM ATP, 10mM
CTP, 0.05mM UTP and 25mCi
32P-labeled UTP for 3h
at 37 C. Cold competitor RNAs were synthesized from
linearized plasmid or PCR-ampliﬁed DNAs using T7
RNA polymerase (Ribomax T7; Promega). After incuba-
tion, all transcription reactions were treated with DNase I
for 20min and then phenol–chloroform-extracted. The
aqueous phase was passed through a Micro Bio-Spin
P30 column according to manufacturer’s instructions
(Bio-Rad).
Preparation of extracts
McArdle 7777 cells were grown in DMEM/F12 media
containing 10% fetal bovine serum (FBS). Nuclear and
cytosolic extracts were isolated as previously described
(26). Protein concentrations were determined using the
Bio-Rad protein assay using IgG as a standard.
UV crosslinking assays
UV crosslinking assays were performed in crosslink buﬀer
(10mM N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic
acid (HEPES) pH 7.9, 100mM KCl, 12.5% glycerol,
0.75mM MgCl2, 0.1mM ethylenediaminetetraacetic acid
(EDTA), 0.25 mM dithiothreitol (DTT)], with 27ng yeast
tRNA (Invitrogen) and 12U RNase inhibitor (Roche).
Reactions contained 20fmol
32P-labeled probe
(22000cpm/fmol) and cell extracts or puriﬁed nucleolin
(Vaxron) as indicated in the ﬁgure legends. Each
reaction was treated with UV irradiation (Bio-Rad GS
Genelinker) for 10min at 254nm in a 96-well tissue
culture plate (Corning). Samples were digested using
RNase A (1mg/ml) for 1h at 37 C, analyzed by 10%
(w/v) SDS–PAGE and detected by autoradiography.
Quantitation was performed using a Storm 800 Imager
and ImageQuant software (Molecular Dynamics). For
competition experiments, proteins were pre-incubated
with various concentrations of unlabeled SECIS RNAs
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32P-labeled PHGPx probe.
Protein puriﬁcation and peptide sequencing
Nuclear extracts from McArdle 7777 cells were
precipitated sequentially with 0–20, 20–40 and 40–60%
ammonium sulfate (AMS). As the bulk of the 110kDa
crosslinking activity was detected in the 40–60% AMS
fraction, this fraction was further puriﬁed by RNA
aﬃnity chromatography. The rat PHGPx SECIS RNA
was coupled to cyanogen bromide-activated Sepharose
4B as described (29). The 40–60% AMS fraction was
adsorbed to the column in binding buﬀer, and the
column was extensively washed. Bound proteins were
step-eluted with binding buﬀer containing 0.5M NaCl
(29). The eluted proteins were concentrated, separated
by SDS–PAGE, and visualized by Coomassie Blue
staining. The bands were excised from the gel and
submitted for peptide sequence analysis using a
Finnegan LCQ ion trap mass spectrometer. The protein
was reduced, alkylated and digested with trypsin. The re-
sulting peptides were analyzed by capillary column
LC-tandem mass spectrometry. The CID spectra were
used to search against the non-redundant database using
a mammalian taxonomy ﬁlter.
Immunodepletion studies
MagnaBind Protein A magnetic beads (Pierce) were
washed three times with NET2 buﬀer [10mM tris(hydrox-
ymethyl)aminomethane (TRIS), 150mM sodium chloride
(NaCl), 0.05% (v/v) Nonidet-P40] and incubated with two
diﬀerent aﬃnity-puriﬁed anti-nucleolin antibodies (Sigma
[N2662] and Novus Biologicals [NB100-2239]) or puriﬁed
mouse IgG in 0.1M sodium phosphate buﬀer, pH 8.1 for
1h at room temperature on a rotator. The samples were
then placed on a magnetic stand to capture the
bead-antibody complexes, and the beads were washed
once with crosslink buﬀer. Nuclear extract from
McArdle 7777 cells (30mgi n2 5 ml total volume of
crosslink buﬀer) was added to the beads and incubated
at room temperature for 1h on a rotator. After incuba-
tion, samples were placed on a magnetic stand to capture
the complexes. The supernatants were removed and
analyzed by UV crosslinking.
RNA electrophoretic mobility shift assays
The
32P-labeled PHGPx SECIS RNA (10fmol) was
heated at 95 C and slow cooled to room temperature.
The RNA was then incubated with increasing amounts
of nucleolin protein puriﬁed from HeLa cells (Vaxron),
in 20ml crosslink buﬀer. Incubations were done at 37 C
for 30min and the resulting RNA–protein complexes were
resolved on 4% non-denaturing polyacrylamide gels. The
gels were dried, and the signals were quantiﬁed using a
Storm 800 Imager and ImageQuant software (Molecular
Dynamics). Competition experiments with cold RNAs
were performed as described above for the UV
crosslinking assays.
Co-immunoprecipitation
Nuclear extracts from McArdle 7777 cells were incubated
at 4mg/ml in crosslink buﬀer containing 0.2mM EDTA
and 0.5mM DTT, with the two aﬃnity-puriﬁed
anti-nucleolin antibodies described above or puriﬁed
mouse IgG for 1h at 4 C. The immune complexes were
removed by incubation with recombinant Protein
A-Sepharose (Zymed). The resin was washed ﬁve times
with NET2 buﬀer, and RNA was extracted directly from
the beads in 300ml Trizol according to manufacturer’s
protocol (Invitrogen). RNA was resuspended in 10ml
RNase-free water for subsequent cDNA synthesis.
Quantitative real-time PCR
Equal volumes of the co-immunoprecipitated RNAs were
used as templates for cDNA synthesis. All cDNAs were
synthesized using the TaqMan Reverse Transcription
Reagents kit, based on the manufacturer’s instructions
and suggested thermal cycling proﬁle (Applied
Biosystems). Quantitative real-time PCR (qRT-PCR)
was performed using SYBR Green PCR Master Mix
and the ABI PRISM 7000 Sequence Detection System
(SDS; Applied Biosystems), under conditions recom-
mended in the instructions. Primers used for qRT-PCR
are listed in Supplementary Table S2. The results were
analyzed with ABI PRISM SDS software from Applied
Biosystems, using the IgG sample as a control for relative
selenoprotein mRNA expression in the immunopre-
cipitates. Relative gene expression was calculated using
the 2
 CT method (30). For siRNA experiments, 2mg
of RNA from the harvested cells was used as a template
for cDNA synthesis using the same method described
above. qRT-PCR and gene expression analysis were per-
formed as described above and the results were
normalized to GAPDH mRNA levels. For analyzing the
subcellular distribution of speciﬁc transcripts, qRT-PCR
was performed using RNA extracted from nuclear
extracts, which were prepared as described above.
siRNA experiments
Four synthetic ON-TARGETplus siRNA duplexes
against rat nucleolin were purchased from Dharmacon
(Catalog #J-087768-05, J-087768-06, J-087768-07 and
J-087768-08). Accell non-targeting siRNA #1
(Dharmacon) was used as a negative control, which we
term NT siRNA. McArdle 7777 cells were seeded at a
density of 3 10
5 in 6-well cell culture plates and grown
in DMEM/F12 media supplemented with 10% FBS for
24h. At 40% conﬂuency, cells were transfected with
67nM siRNAs using Dharmafect 4 reagent, according
to the manufacturer’s instructions (Dharmacon). After
72–96h, cells were harvested for RNA using Trizol ac-
cording to manufacturer’s instructions (Invitrogen), or
for total protein, as follows. Cells were washed in
1 Dulbecco’s phosphate-buﬀered saline (D-PBS) and
collected in a microcentrifuge tube. After centrifugation,
the cell pellets were resuspended in two packed cell
volumes of lysis buﬀer (0.3M HEPES pH 7.4, 1.4M
KCl, 30mM MgCl2, 0.05% NP-40) and incubated on ice
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r.p.m. for 20min at 4 C. The supernatants were analyzed
by western blotting for nucleolin expression and mRNA
levels from the RNA extracts were analyzed using
qRT-PCR. Maximal knockdown of nucleolin was
achieved after 96h using siRNAs J-087768-07 and
J-087768-08, which will be referred to as siRNAs 7 and
8, respectively. These siRNAs and conditions were subse-
quently used to analyze the eﬀects on selenoprotein
expression.
Western blotting
Proteins were electrophoresed on SDS–PAGE gels and
transferred to ImmunoBlot polyvinylidene ﬂuoride
(PVDF) membrane (BioRad). The primary antibodies
used were a-NCL rabbit polyclonal antibody (Sigma,
N2662), a-PHGPx rabbit polyclonal antibody, a-GPx1
rabbit polyclonal antibody (Abcam, ab22604),
a-GAPDH (6C5) mouse monoclonal antibody (Abcam,
ab8245), a-TXNRD1 (TR1) rabbit polyclonal antibody
(ProteinTech Group, 11117-1-AP), a-SEP15 mouse poly-
clonal antibody (Abnova, H00009403-A01), a-histone H1
mouse monoclonal antibody (Santa Cruz, SC-56694) and
b-tubulin isotype I and II antibody (Sigma, T8535). The
secondary antibodies used were either a-rabbit-HRP or
a-mouse-HRP (Jackson Immunochemicals). Proteins
were detected using Immobilon Chemiluminescent HRP
detection substrate (Millipore), and exposure to BioMax
MR ﬁlm (Kodak). Analysis was performed using
ImageQuant RT ECL (GE Healthcare).
RESULTS
Identiﬁcation of a 110kDa SECIS-binding protein
In order to identify SECIS-binding proteins, UV
crosslinking experiments were carried out using nuclear
and cytosolic extracts from McArdle 7777 cells, a rat
hepatoma cell line that expresses PHGPx, GPx1 and
several other selenoproteins. The extracts were analyzed
by western blotting using antibodies to histone H1
or b-tubulin as nuclear and cytosolic markers, respective-
ly, to monitor the purity of the fractions. As shown
in Figure 1A, the nuclear and cytosolic extracts were
relatively free of contamination from the other subcellular
compartment. The extracts (0–20mg) were incubated
with the
32P-labeled wild-type PHGPx SECIS, which is
a Type 2 element. Proteins were crosslinked to the RNA
by exposure to UV radiation. Following degradation of
the unbound RNA by RNase A, the samples were
separated by SDS–PAGE and analyzed by autoradiog-
raphy (Figure 1B). A prominent band of 110kDa, which
was detected in both nuclear and cytosolic extracts,
crosslinked to the PHGPx SECIS in a dose-dependent
manner. To assess speciﬁcity, crosslinking experiments
were also performed with an irrelevant RNA correspond-
ing to region 1 of the SBP2 30UTR (26). This RNA is
predicted to form a stable stem-loop structure, with two
stems, an internal loop and an apical loop, similar to a
SECIS element. In contrast to the results obtained with
the PHGPx SECIS, we did not detect a strong signal
Figure 1. Identiﬁcation of a 110kDa SECIS-binding protein.
(A) Nuclear and cytosolic extracts (30 mg protein) were analyzed by
SDS–PAGE and western blotting using antibodies against histone H1
(nuclear marker) and b-tubulin (cytosolic marker) as indicated. The
arrows indicate the positions of histone (left panel) and b-tubulin
(right panel). (B) The
32P-labeled wild-type PHGPx SECIS probe was
incubated with increasing amounts (2.5–20mg) of nuclear or cytosolic
extracts from McArdle 7777 cells in a UV crosslinking assay. The
samples were analyzed by SDS–PAGE and autoradiography. The
110kDa protein is indicated by the arrow. The band of  50 kDa,
indicated by the asterisk, may represent a non-speciﬁc RNA-binding
protein. (C) UV crosslinking experiments were performed with 2.5, 5 or
10 mg of nuclear or cytosolic extracts as described in (A) except that the
32P-labeled probe was either the PHGPx SECIS or an irrelevant RNA
(region 1 from the SBP2 30 UTR) that does not contain a SECIS but is
predicted to form a stem-loop structure.
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plasmic extracts when the crosslinking experiments were
performed with the
32P-labeled region 1 probe. The
nuclear and cytosolic extracts both contained a protein
of  50kDa, which crosslinked to the PHGPx SECIS
(Figure 1B) and the SBP2 region 1 RNA (Figure 1C).
The identity of the 50kDa protein (indicated by the
asterisk in Figure 1) is not known but it may represent a
non-speciﬁc RNA-binding protein.
The 110kDa protein requires the upper part of the basal
stem for binding to the SECIS
As the speciﬁc activity of the 110kDa crosslinking activity
was higher in the nuclear fraction compared to the cytosol
(Figure 1B), subsequent experiments were performed
using the nuclear extract. To identify nucleotide sequences
that are required for binding of the 110kDa protein,
we performed UV crosslinking/competition assays in
which increasing amounts of wild-type or mutant
PHGPx SECIS RNAs were added to the reaction. We
ﬁrst tested the importance of the AAR motif, which is
essential for Sec incorporation but has no known
function, by generating a loopless RNA that lacks the
AAR motif and apical loop (Figure 2A). As shown in
Figure 2B, the wild-type SECIS of 200 nt and the
loopless RNA were both able to compete for crosslinking
of the 110kDa protein to the
32P-labeled PHGPx SECIS
probe. We then analyzed mutant RNAs that ranged in size
from 155 to 81 nt due to sequential deletion of the basal
stem (Figure 2A). The 155, 129 and 102 nt RNAs were all
eﬀective competitors (Figure 2C). In contrast, the 81 nt
SECIS did not compete at a 250- or 500-fold molar excess.
Thus, binding of the 110kDa protein to the PHGPx
SECIS requires the upper part of the basal stem but not
the AAR motif or apical loop.
The 110 kDa protein distinguishes between
SECIS elements
The 110kDa protein may represent a general
SECIS-binding protein or it may selectively bind to a
subset of selenoprotein mRNAs. In order to distinguish
between these two possibilities, mammalian SECIS
elements were analyzed for their ability to compete for
crosslinking of the 110kDa protein. Figure 3A shows a
typical experiment in which crosslinking of the 110kDa
protein to the
32P-labeled wild-type PHGPx SECIS is
nearly eliminated in the presence of the cold PHGPx
SECIS but not the GPx1 SECIS competitor RNA. A
range of cold competitor concentrations was tested to cal-
culate an IC50 as a measure of relative binding aﬃnity of
the 110kDa protein. This value represents the fold molar
excess of cold competitor over the labeled RNA that
Figure 2. Analysis of mutant PHGPx SECIS RNAs to deﬁne the
binding site requirements for the 110 kDa protein. (A) Schematic of
the PHGPx wild-type SECIS (200 nt), the loopless mutant RNA, and
the basal stem deletion mutants of 155, 129, 102 or 81 nt. (B) Nuclear
extract from McArdle 7777 cells (2 mg) was preincubated with buﬀer or
increasing amounts (0–200-fold molar excess over the probe) of un-
labeled wild-type or loopless PHGPx SECIS RNAs for 10 min prior
to the addition of the
32P-labeled PHGPx SECIS probe. The 110 kDa
crosslinked product is indicated by the arrow and the asterisk indicates
the 50 kDa protein of unknown identity. (C) Competition experiments
were performed as in (B) using 5.5 mg nuclear extract and increasing
amounts (0–500-fold molar excess) of cold basal stem deletion mutant
RNAs of 155, 129, 102 and 81 nt, as indicated.
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Figure 3A, the IC50 of the PHGPx SECIS was   24-fold
lower than the IC50 of the GPx1 SECIS. Thus the 110kDa
protein binds to the PHGPx SECIS with higher aﬃnity
than to the GPx1 SECIS. We then analyzed an additional
10 mammalian SECIS elements as competitors in UV
crosslinking assays. Figure 3B shows that there is a
spectrum of IC50 values, which ranged from 7- to
470-fold molar excess over the labeled RNA. Similar
results were obtained when UV crosslinking experiments
were performed using nuclear extracts from HeLa cells
(data not shown). We wondered whether there was a cor-
relation between protein binding and the type of SECIS
structure. The 110kDa protein binds with high aﬃnity to
a subset of Type 2 SECIS elements, including TR1,
PHGPx, and SelW (Figure 3B). However, this structure
alone is not required for binding as evidenced by mouse
SelR and SelN, which are Type 1 elements that contain the
AAR motif in the apical loop, and by SelO, which has a
non-canonical CCC motif in place of AAR. The type 2
structure is also not suﬃcient since the 110kDa protein
binds with low aﬃnity to Sel15 and SelT, which are Type 2
elements (Figure 3B).
Puriﬁcation and identiﬁcation of the 110kDa
protein as nucleolin
For puriﬁcation of the 110kDa protein, nuclear extracts
from McArdle 7777 cells were precipitated with 0–20,
20–40 and 40–60% AMS. The bulk of the crosslinking
activity was retained in the 40–60% fraction. This
fraction was then puriﬁed by RNA aﬃnity
Figure 4. Puriﬁcation and identiﬁcation of the crosslinking activity. (A) The fraction eluted from the PHGPx RNA aﬃnity column was analyzed by
SDS–PAGE and Coomassie Blue staining. The 110 and 98 kDa proteins indicated by the arrows were submitted for peptide sequence analysis by
mass spectrometry and both bands were identiﬁed as nucleolin. (B) Nuclear and cytosolic extracts (30 mg) were analyzed by western blotting using an
anti-nucleolin antibody. The arrow indicates the position of nucleolin. (C) Nuclear extracts from McArdle 7777 cells (30 mg) were immunodepleted
with puriﬁed IgG or aﬃnity puriﬁed anti-nucleolin antibodies (a-NCL-1, from Sigma; or a-NCL-2, from Novus Biologicals). Aliquots of starting
material (Start) and the depleted extracts were analyzed by UV crosslinking with the
32P-labeled wild-type PHGPx SECIS probe as described in the
legend to Figure 1. The 110 kDa crosslinked product is indicated by the arrow. The asterisk indicates an unidentiﬁed protein of  50 kDa. (D) The
32P-labeled wild-type PHGPx SECIS (top) or loopless RNA (bottom) probes were incubated in the presence of varying amounts of nucleolin puriﬁed
from HeLa cells as indicated. The samples were analyzed by UV crosslinking. The arrow indicates the position of the crosslinked product. (E)
REMSA assay using the
32P-labeled wild-type PHGPx SECIS probe, which was incubated with increasing amounts of nucleolin puriﬁed from HeLa
cells, as indicated. The reactions were analyzed by non-denaturing polyacrylamide gel electrophoresis and autoradiography. The nucleolin:SECIS
complexes (NCL:SECIS) are indicated by a bracket. The asterisk may represent a slowly migrating conformation of probe.
Figure 3. The 110 kDa protein distinguishes among SECIS elements. (A) The inset shows a representative UV crosslinking competition experiment
in which nuclear extracts and the
32P-labeled wild-type PHGPx SECIS were incubated in the presence of increasing amounts of cold PHGPx or GPx1
SECIS RNAs. The arrow indicates the position of the 110 kDa protein. The graph shows the quantitation of competition experiments. The IC50
values were calculated as described in ‘Materials and Methods’ section, and the results represent the data from three or more experiments (B)U V
crosslinking competition experiments were performed as described in the legend to Figure 2B. Crosslinking of the 110 kDa protein to the
32P-labeled
PHGPx SECIS was competed using increasing amounts of unlabeled SECIS RNAs from 12 mammalian selenoproteins. The IC50 values were
calculated as described in ‘Materials and Methods’ section. The data for each SECIS element represent the mean from three or more
experiments±SD.
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described in ‘Materials and Methods’ section. Bound
proteins were step-eluted with 0.5 M NaCl. The eluate
was concentrated for separation by SDS–PAGE and visu-
alization by Coomassie Blue staining. The eluted fraction
contained several proteins, including a 110kDa protein
and a more prominent band of 98kDa (indicated by the
arrows in Figure 4A). The bands were excised from the gel
and submitted for peptide sequence analysis by mass spec-
trometry. Both bands were identiﬁed as nucleolin, with six
peptides covering 14% of the sequence for the 110kDa
protein and 29 peptides covering 38% of the sequence
for the 98kDa protein. The 98kDa protein presumably
represents a degradation product that was generated
during puriﬁcation.
Nucleolin is a highly conserved protein that contains
multiple domains: an N-terminal region rich in acidic
amino acids; a central domain with four non-identical
RNA recognition motifs (RRM) that function in
RNA-binding; and a C-terminal region with multiple
RGG repeats that mediates protein–protein interactions
(31). Based on the cDNA sequence, nucleolin is predicted
to be 77kDa, but the protein migrates anomalously at
110kDa on SDS–PAGE due to the highly acidic
N-terminus. Western blot analysis using an anti-nucleolin
antibody detected the protein in nuclear and cytosolic
extracts from McArdle 7777 cells (Figure 4B). We also
performed immunodepletion experiments to conﬁrm that
the 110kDa band detected by crosslinking is nucleolin.
Nuclear extracts from McArdle 7777 cells were incubated
with two diﬀerent aﬃnity-puriﬁed anti-nucleolin
antibodies or puriﬁed IgG. The immune complexes were
removed by binding to protein A magnetic beads and
the unbound fractions were assayed by UV crosslinking
using the
32P-labeled PHGPx SECIS probe. As shown in
Figure 4C, the 110kDa crosslinking band was substantial-
ly depleted by the anti-nucleolin antibodies but not by the
IgG control.
In order to determine whether nucleolin binds directly
to the SECIS or whether this activity depends on other
Figure 5. Puriﬁed nucleolin shows selective SECIS-binding activity. (A) REMSA competition experiments were performed using nucleolin puriﬁed
from HeLa cells (25 ng), the
32P-labeled PHGPx SECIS probe, and the wild-type PHGPx SECIS or the 81 nt basal stem deletion mutant RNAs
as described in the legend to Figure 2B. Cold RNAs were added at 0, 25, 50, 100 or 200-fold molar excess over the probe. The brackets indicate
the position of the nucleolin:SECIS complex (NCL:SECIS) and the arrow indicates the free probe. (B) REMSA competition experiments were
performed as described in (A) except the competitor RNAs included the wild-type PHGPx SECIS and three irrelevant RNAs [HSR from the
VEGF-A 30 UTR (27), region 1 from the SBP2 30 UTR which was tested in Figure 1C, and an RNA corresponding to region 2 of the SBP2 30 UTR
(see ‘Materials and Methods’ section and Supplementary Table S1 for details)]. The RNAs were added at 0, 5, 10 and 20-fold molar excess over
the probe. (C) REMSA competition experiments were performed using cold long (1550 nt) and short (207 nt) TR1 SECIS RNAs, which were added
at 0, 2.5, 5, 10 and 20-fold molar excess. (D) UV crosslinking competition experiments in which puriﬁed nucleolin (20 ng) was incubated with
32P-labeled wild-type PHGPx SECIS probe. Various amounts of unlabeled SECIS RNAs (PHGPx, SelR, Sel15 or GPx1) were added to the binding
reaction in molar excess over the labeled probe as indicated. The arrow indicates the position of the crosslinked product. No other bands were
detectable on the autoradiogram.
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ments using nucleolin puriﬁed from HeLa cells. The
puriﬁed protein crosslinked to the
32P-labeled PHGPx
SECIS and to the loopless RNA in a dose-dependent
manner, with a signal detected using as little as 3ng of
protein (Figure 4D). We also analyzed nucleolin–SECIS
interactions using RNA electrophoretic mobility shift
assay (REMSA). The
32P-labeled PHGPx SECIS was
incubated with puriﬁed nucleolin and the samples were
analyzed by electrophoresis on native gels. As shown in
Figure 4E, the probe shifted upwards in a dose-dependent
manner in the presence of nucleolin. The nucleolin–SECIS
complex appeared as a discrete band within a smear, pre-
sumably due to the dissociation of the complex during
electrophoresis. Approximately 50% of the probe was
shifted by 40–50ng of protein. This corresponds to an
apparent KD of  30nM, which is similar to the aﬃnity
of nucleolin for other known targets.
Puriﬁed nucleolin shows selective SECIS-binding activity
We next assessed the speciﬁcity of nucleolin binding
by performing competition experiments, which were
analyzed by REMSA. As shown in Figure 5, the puriﬁed
nucleolin exhibits sequence-speciﬁcity similar to the
crosslinking activity detected in crude extracts. Binding
of nucleolin was eﬀectively competed by the wild-type
PHGPx SECIS but not by the 81 nt basal stem deletion
mutant, even at a 200-fold molar excess (Figure 5A). We
also tested three non-SECIS RNAs that are predicted to
form stem-loop structures, including the HSR of the
VEGF-A 30 UTR (27), region 1 from the SBP2 30 UTR
which was used in Figure 1C, and an RNA corresponding
to region 2 from the SBP2 30 UTR. A 20-fold molar excess
of the cold PHGPx SECIS RNA reduced the REMSA
signal by 70% whereas the three irrelevant RNAs were
not eﬀective competitors at the same concentration
(Figure 5B). In terms of selectivity, our crosslinking ex-
periments with crude extracts suggested that nucleolin
bound with the highest aﬃnity to the TR1 SECIS.
However, the RNA used for this experiment was  1550
nt long, compared to an average size of 250 nt for the
other SECIS elements that were tested (Supplementary
Table S1). Therefore we generated a short TR1 SECIS
RNA of 207 nt. As shown in Figure 5C, both the long
and short TR1 SECIS RNAs were very eﬀective competi-
tors, reducing the signal by 75–80% at 2.5-fold molar
excess. Thus RNA length alone is not suﬃcient to
explain high aﬃnity binding.
We also analyzed the selectivity of nucleolin binding
using UV crosslinking/competition assays since the
signal is easier to quantify with this method. As shown
in Figure 5D, a 10-fold molar excess of the PHGPx
SECIS reduced the signal by  40% whereas the
crosslinking signal was decreased by  60% with a 5-fold
molar excess of the SelR SECIS. In contrast, a 40-fold
molar excess of Sel15 SECIS RNA or 160-fold molar
excess of GPx1 SECIS RNA (Figure 5D) was required
to compete away  50% of the labeled PHGPx SECIS
probe (Figure 5D). Thus, nucleolin can discriminate
between SECIS elements in the absence of SBP2, L30 or
other cellular proteins.
Co-immunoprecipitation of nucleolin–RNA complexes
from cells
To establish invivo relevance, we wanted to determine
whether nucleolin is associated with selenoprotein
mRNAs in cells. This was of particular interest as
nucleolin showed selective SECIS-binding activity in our
invitro assays, but a recent study reported that all
selenoprotein mRNAs were co-immunoprecipitated with
similar eﬃciency by an anti-nucleolin antibody compared
to the IgG control (22). However, it is important to note
that the latter study examined only selenoprotein mRNAs.
We performed co-immunoprecipitation experiments using
extracts from McArdle 7777 cells and the two
anti-nucleolin antibodies that were eﬀective in the
immunodepletion experiments described above or
puriﬁed IgG as the negative control. RNAs were
isolated from the immune complexes and used as tem-
plates in cDNA reactions, which were analyzed by
qRT-PCR using gene-speciﬁc primers. The mean
crossing points were calculated for PCR products
derived from three independent immunoprecipitations
(two performed with one anti-nucleolin antibody and
one performed with the other). The results were expressed
as the change in mean crossing points for the
anti-nucleolin samples over the IgG controls (Figure 6).
We found that the anti-nucleolin antibodies immunopre-
cipitated the PHGPx, TR1, Sel15 and GPx1 mRNAs,
with mean crossing point changes that ranged from 8.6
to 9.8 compared to the IgG control. These results are
similar to those reported by Squires etal. (22). However,
b-actin and GAPDH were also preferentially
Figure 6. Co-immunoprecipitation of selenoprotein mRNAs with
nucleolin:RNA complexes from cells. Nucleolin:RNA complexes were
immunoprecipitated from McArdle 7777 cell nuclear extracts using two
diﬀerent anti-nucleolin antibodies or a puriﬁed IgG control as described
in ‘Materials and Methods’ section. Total RNA was isolated from the
immune complexes, and analyzed by qRT-PCR analysis using
gene-speciﬁc primers. The results are expressed as change in crossing
points (mean±SD) for PCR products derived from the anti-nucleolin
samples compared to the IgG controls. The data represent the
combined results from three independent immunoprecipitation experi-
ments using the two diﬀerent anti-nucleolin antibodies.
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anti-nucleolin antibodies, with mean crossing point
changes of 9.6 and 8.5, respectively, over the IgG
control (Figure 6). These results suggest that the
co-immunoprecipitation experiments presented here and
in ref. (22) may not be detecting true invivo interactions.
siRNA knockdown of nucleolin selectively inhibits
PHGPx and TR1 expression
In order to elucidate the role of nucleolin in selenoprotein
synthesis, we used siRNAs to knockdown nucleolin ex-
pression in McArdle 7777 cells. The conditions for
maximal knockdown were optimized as described in
‘Materials and Methods’ section. Cells were transfected
for 96h with two diﬀerent siRNAs against nucleolin
(siRNAs 7 and 8) or a non-targeting (NT) siRNA as a
negative control. The cell lysates from three independent
transfections were analyzed by western blotting. As shown
in Figure 7A and B, each of the nucleolin siRNAs reduced
nucleolin expression by  6-fold, whereas the NT control
siRNA had no eﬀect. There was a 2.3- and 2.7-fold reduc-
tion in PHGPx protein levels in cells treated with siRNAs
7 and 8, respectively, which was not observed in the NT
siRNA-treated cells (Figure 7C and D). We also observed
a modest but statistically signiﬁcant decrease in TR1
protein levels in the nucleolin siRNA-treated cells, with
siRNAs 7 and 8 causing a 1.2- and 1.4-fold reduction,
respectively (Figure 7C and D). The decrease that we
observed for TR1 is likely to be an underestimate as this
selenoprotein contains the Sec residue near the
C-terminus. Thus the full-length TR1 and the truncated
protein that lacks Sec cannot be distinguished by
SDS–PAGE. The eﬀect of the nucleolin siRNAs on
PHGPx and TR1 expression was speciﬁc, as the
knockdown of nucleolin did not alter the levels of GPx1
and Sel15, which are encoded by mRNAs containing
SECIS elements that are bound by nucleolin with low
aﬃnity, or of GAPDH, which is not a selenoprotein
(Figure 7C and D). Thus, there is a good correlation
between the aﬃnity of nucleolin for a SECIS element
and its ability to enhance selenoprotein expression.
In terms of mechanism, nucleolin has been shown to
stabilize a number of cellular mRNAs by binding to the
30UTR of the transcript (32–35). Therefore, we analyzed
transcript levels in the siRNA-treated cells by qRT-PCR.
The results were normalized to GAPDH. As shown in
Figure 7E, the knockdown of nucleolin did not reduce
PHGPx, TR1 or b-actin mRNA levels. Thus, the
decrease in PHGPx and TR1 protein that was observed
in the nucleolin siRNA-treated cells was not due to a re-
duction in transcript abundance. We also tested the pos-
sibility that nucleolin may be involved in mRNA export
by performing qRT-PCR analysis of RNA isolated from
nuclear extracts of siRNA-treated cells. As shown in
Figure 7F, siRNA knockdown of nucleolin did not alter
the nuclear levels of the transcripts encoding PHGPx, TR1
and b-actin. Thus, nucleolin does not appear to stimulate
selenoprotein expression by facilitating nuclear export of
the transcript. Taken together, these results suggest that
nucleolin may selectively enhance the expression of
PHGPx and TR1 at the translational level.
DISCUSSION
The co-translational incorporation of Sec into
selenoproteins is a complex process that requires both
cis-acting sequences in the transcript and multiple trans-
acting factors. As the UGA recoding machinery is limiting
in cells, it is likely that selenoprotein synthesis needs
to be tightly regulated invivo in order to ensure the
proper expression of the selenoproteome. The SECIS
element plays an essential role in this mechanism by
acting as a platform for RNA-binding proteins.
Although mammalian SECIS elements all contain a
stem-loop, they vary in their structure and composition,
which raises the possibility that each SECIS may re-
cruit a diﬀerent spectrum of proteins. In the current
study, we present several lines of evidence that strongly
support the hypothesis that nucleolin selectively binds
with high aﬃnity to SECIS elements from PHGPx and
other selenoprotein mRNAs to enhance their translation
in cells.
Nucleolin is an abundant multi-functional protein
found in a variety of subcellular locations (31,36), As
the major protein in the nucleolus, nucleolin plays a
critical role in ribosome biogenesis by interacting with
both pre-ribosomal RNA and ribosomal proteins. The
protein is also found in the nucleus where it promotes
the transcription of rRNA genes and modulates chroma-
tin structure. Although nucleolin shuttles between the
nucleus and cytoplasm, the protein is not found on
mature ribosomes. Instead cytoplasmic nucleolin has
been shown to regulate the stability or translation of
several cellular and viral mRNAs (32–35,37,38).
Nucleolin is also found on the cell surface where it binds
a number of ligands (31,36). In light of the newly dis-
covered functions of nucleolin outside of the nucleolus,
it is reasonable to consider that this protein may be
involved in the regulation of selenoprotein synthesis. In
fact, nucleolin was previously identiﬁed as a potential
SECIS-binding protein based on ligand screening of a bac-
terial expression library with a radiolabeled GPx1 SECIS
element (39). However, the aﬃnity of nucleolin for other
SECIS elements and the relevance of nucleolin to
selenoprotein synthesis were not investigated in this
earlier study.
Our invitro binding assays showed that nucleolin
binds with high aﬃnity to SECIS elements from a
subset of selenoprotein mRNAs. Interestingly co-
immunoprecipitation studies perform by Squires etal.
(22) and our group (Figure 6) failed to detect selective
nucleolin–SECIS interactions in cells. The most likely ex-
planation for the discrepancy between the invitro binding
and cell culture results is that UV crosslinking experiments
are performed with shorter RNAs that encompass the
SECIS element, not the entire transcript. In contrast, the
co-immunoprecipitation experiments can detect inter-
actions between nucleolin and full-length endogenous
mRNAs, which may contain many high or low aﬃnity
Nucleic Acids Research, 2010,Vol.38, No. 14 4815binding sites. Nucleolin may have associated with cellular
mRNAs after the cells were lysed or during the
immunoprecipitation step. Indeed a non-speciﬁc associ-
ation between nucleolin and GAPDH mRNA in
co-immunoprecipitation experiments has been previously
reported (37). There is also evidence in other systems that
post-lysis reassortment of some RNA–protein interactions
can occur (40).
Figure 7. Selective inhibition of PHGPx and TR1 expression due to siRNA knockdown of nucleolin. (A) McArdle 7777 cells were treated with
siRNAs directed against nucleolin (siRNA 7 and 8) or a NT siRNA for 96 h as described in ’Materials and Methods’ section. Cell lysates were
analyzed by western blotting using the indicated antibodies. (B) Quantitation of the western blot data from three independent experiments. The
results were normalized to GAPDH and are represented as mean±SEM. Asterisks indicate signiﬁcant change in protein expression for the nucleolin
siRNA treated cells relative to the cells treated with the NT siRNA (single asterisk indicates P<0.001). (C) As described in (A), cell lysates were
analyzed by western blotting using the indicated antibodies. The PHGPx and GPx1 antibodies also recognize two non-speciﬁc bands of 34 and
52 kDa, which are not shown in this ﬁgure but did not change with siRNA treatment. The bands shown in the ﬁgure correspond to the speciﬁc bands
for PHGPx and GPx1 proteins at 20 and 26 kDa, respectively. (D) Quantitation and statistics were performed as described in (B) (single asterisk
indicates P<0.001, double asterisk indicates P<0.05). (E) Eﬀect of nucleolin manipulation on PHGPx and TR1 mRNA levels. Total RNA was
isolated from McArdle 7777 cells treated with nucleolin siRNAs 7 and 8 or the NT control for 96 h. The levels of b-actin, PHGPx and TR1 mRNAs
were quantiﬁed by qRT-PCR. The results were normalized to GAPDH and expressed as fold-change. The data represent the mean from at least three
independent analysis±SEM. (F) Transcript levels in nuclear extracts were quantiﬁed by qRT-PCR as described in (E).
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invitro raises the question as to how it distinguishes
among SECIS elements. As nucleolin contains four
non-identical RRM domains, it is not surprising that the
protein interacts with a variety of diﬀerent targets. The
RRM is a well-characterized RNA-binding domain of
80–90 amino acids that is found in many proteins
involved in RNA processing or metabolism (41). For
proteins that contain multiple RRMs, each RRM may
bind a diﬀerent sequence, or a subset of the RRM
domains may be required for sequence-speciﬁc binding
(42). In the case of nucleolin, the protein binds to two
mutually exclusive binding sites in pre-rRNAs: the
nucleolin recognition element (NRE) and the evolutionar-
ily conserved motif (ECM). The NRE is a short
single-stranded sequence (U/GCCCGA/G) found within
the loop of a stem-loop structure in pre-rRNAs (43,44).
The nucleolin–NRE interaction is mediated by RRMs 1
and 2 (45). In contrast, binding of nucleolin to the ECM,
an 11-nt motif (GATCGATGTGG), requires all four
RRMs (46). In addition to the NRE and ECM, nucleolin
interacts with a variety of distinct sequences in the 50 or
30UTRs of cellular transcripts, including AU-rich elements
in the Bcl-2 and Bcl-XL mRNAs (47). The binding sites for
nucleolin in the 30UTR of the amyloid precursor protein
mRNA and the 50UTR of the interleukin-2 mRNA have
not been ﬁnely mapped but they both contain the
sequence CUCUCUUUA (35). A similar CU-rich region
is present in the 30UTR of another nucleolin target, the
CD154 mRNA (34). In contrast, the determinant for
nucleolin binding to the 30UTR of the b-globin mRNA
is a G-rich sequence in a stem structure opposite a
CU-rich region (32). In addition to the known binding
sites for full-length nucleolin, a 64kDa form of the
protein, presumably generated by autocatalytic cleavage,
binds to the sequences UAAAUC or AAAUCU in the
50UTR of the collagen prolyl 4-hydroxylase-a(I) mRNA
(48). Based on nucleotide sequence analysis, we have not
yet been able to identify a motif that is common to SECIS
elements that are bound by nucleolin with high aﬃnity.
Our results suggest that binding of nucleolin to the
PHGPx SECIS requires the upper part of the basal stem
(Figure 2C and 5A) but not the AAR motif or apical loop
(Figure 2B and 4D). Whether nucleolin binds directly
to the upper part of the basal stem and whether this
interaction depends on the nucleotide sequence and/or
secondary structure of the SECIS is currently under
investigation.
Our siRNA experiments found that the knockdown of
nucleolin resulted in a decrease in PHGPx and TR1
protein levels but had no eﬀect on Sel15 and GPx1 expres-
sion. Importantly, the levels and subcellular localization
of the transcripts did not change in the siRNA-treated
cells. These results suggest that nucleolin acts as a
positive regulator for the translation of a subset of
selenoprotein mRNAs, including PHGPx and TR1. Do
the transcripts that are bound by nucleolin with high
aﬃnity share a common biological function or biosynthet-
ic pathway? We have not detected any correlation between
binding of nucleolin and the following parameters: known
enzymatic activity of the selenoprotein; tissue-speciﬁc
expression pattern; dependence on the Um34 isoform of
the Sec-tRNA
Sec for synthesis (49); or presence of the
second stop codon redeﬁnition element in the coding
region (50). However, we did note that nucleolin binds
with higher aﬃnity to SECIS elements from
selenoproteins that exhibit a severe phenotype when
deleted in mice and/or rank high in the hierarchy of ex-
pression during selenium deﬁciency. Nucleolin binds the
PHGPx and TR1 SECIS elements with high aﬃnity, and
targeted disruption of either of these genes in mice is em-
bryonic lethal in mice (18,19). Furthermore, these two
selenoproteins, as well as SelW, rank high in the hierarchy
of selenoprotein expression (51,52). Although the SelN
gene has not been disrupted in mice, naturally occurring
mutations in the human gene lead to a group of
early-onset neuromuscular disorders referred to as
SEPN1-related myopathy (53). In contrast, nucleolin
binds the GPx1 SECIS element with low aﬃnity, and
the GPx1 knockout mouse model expresses a normal
phenotype (20,21). In addition, GPx1 ranks low in the
hierarchy of selenoprotein expression (51). Notably,
nucleolin binds the Dio2, GPx2 and Dio1 SECIS
elements with moderate aﬃnity. The expression of these
selenoproteins is preserved when selenium is limiting
(54,55), but the knockout mice have either no phenotype
or a modest phenotype, which suggests that these
selenoproteins perform important but non-essential func-
tions (56–58). The exception to this trend is SelR
(also known as MsrB1), whose SECIS is bound by
nucleolin with very high aﬃnity. Although the SelR
knockout mice exhibit signs of oxidative stress in the
liver and kidney, they have no obvious phenotype (59).
Knockout models for SelO, SelT and Sel15 have not
been reported and it is not known where these
selenoproteins rank in the hierarchy.
An emerging theme in the ﬁeld is that the regulation of
selenoprotein expression is much more complex than pre-
viously anticipated. The aﬃnity of SBP2 for diﬀerent
SECIS elements varies both invitro (23) and invivo (22).
These diﬀerences in the relative binding aﬃnity of SBP2
determine the expression pattern of the selenoproteome
(23). In addition to the components of the basal
recoding machinery, other regulatory factors modulate
the expression of individual selenoproteins. We recently
reported that eIF4a3 binds to the GPx1 and SelR
SECIS elements and represses their translation by prevent-
ing the binding of SBP2 when selenium is limiting (24).
This eﬀect is speciﬁc, as eIF4a3 did not bind to the
PHGPx and TR1 SECIS elements. In contrast, nucleolin
appears to be a selective positive regulator of
selenoprotein expression, binding to the PHGPx and
TR1 SECIS elements, but not to the GPx1 SECIS.
Intriguingly, SelR appears to be an exception as both
nucleolin (this study) and eIF4a3 (24) bind to this
SECIS element with high aﬃnity. As the two proteins
have opposing eﬀects on Sec incorporation, these results
suggest that the expression of SelR may be tightly
regulated at the translational level in diﬀerent cell types
or in response to environmental cues. There is a rapid
increase in eIF4A3 protein when selenium becomes
limiting and we proposed that this up-regulation serves
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expression (24). Interestingly, selenium supplementation
has no eﬀect on nucleolin activity and protein levels in
McArdle 7777 cells. Our results suggest that nucleolin is
required for optimal expression of PHGPx and TR1 but it
is tempting to speculate that nucleolin may play an add-
itional regulatory role since its RNA-binding activity and
subcellular localization respond to a variety of cell stres-
sors (37,47,60,61).
Given the variety of activities that nucleolin can carry
out, there are multiple mechanisms by which this protein
could modulate selenoprotein mRNA translation. There is
precedent for nucleolin acting as a substrate remodeling
factor. Nucleolin has a strand annealing activity (62),
which could be involved in refolding the SECIS structure
into a more favorable substrate for protein–SECIS inter-
actions. Nucleolin also participates in protein–protein
interactions, often through the RGG domains located in
its C-terminus (63). Thus, the SECIS-bound nucleolin
could directly recruit factors involved in Sec incorpor-
ation. Interestingly, a recent study identiﬁed nucleolin as
a cell surface receptor for the bacterial pathogen
Francisella tularensis (64). The ligand for nucleolin was
bacterial elongation factor Tu, which was expressed on
the surface of the bacteria. The ﬁnding that nucleolin
can interact with an elongation factor raises the possibility
that binding of nucleolin to the SECIS may facilitate the
recruitment of the EFsec-Sec-tRNA
Sec complex. Finally,
nucleolin may not aﬀect Sec incorporation directly but
instead may modulate another step in protein synthesis.
It has been proposed that nucleolin enhances the transla-
tional eﬃciency of the matrix-metalloproteinase-9 mRNA
by binding to the 30UTR and recruiting the translationally
inactive mRNA to polysomes (38). Given that the 50- and
30-ends of a transcript interact during translation, there
may be a SECIS-dependent initiation event that is
mediated or regulated by nucleolin. The investigation of
the mechanism of action of nucleolin is an important dir-
ection for future research.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Dr Mike Kinter and Dr Belinda Willard from
the Lerner Research Institute Proteomics Laboratory for
the mass spectrometry analysis; Dr Heiko Mix, Dr Vadim
Gladyshev, Dr Peng Yao and Dr Paul Fox for providing
PCR-ampliﬁed templates for invitro transcription; and Dr
Jodi Bubenik, Dr Tracey Ferrara and Dr Sanghamitra
Bhattacharyya for reading the manuscript.
FUNDING
National Institutes of Health (grant numbers RO1
DK078591 to D.M.D. and F32 DK083154 to M.E.B.);
American Heart Association (Postdoctoral Fellowship to
L.M.M.).Funding for open access charge: National
Institutes of Health (grant numbers RO1 DK078591).
Conﬂict of interest statement. None declared.
REFERENCES
1. Hatﬁeld,D.L., Carlson,B.A., Xu,X.M., Mix,H. and
Gladyshev,V.N. (2006) Selenocysteine incorporation machinery
and the role of selenoproteins in development and health.
Prog. Nucleic Acid Res. Mol. Biol., 81, 97–142.
2. Berry,M.J., Banu,L., Chen,Y.Y., Mandel,S.J., Kieﬀer,J.D.,
Harney,J.W. and Larsen,P.R. (1991) Recognition of UGA as a
selenocysteine codon in type I deiodinase requires sequences in
the 3’ untranslated region. Nature, 353, 273–276.
3. Walczak,R., Carbon,P. and Krol,A. (1998) An essential
non-Watson-Crick base pair motif in 3’UTR to mediate
selenoprotein translation. RNA, 4, 74–84.
4. Walczak,R., Westhof,E., Carbon,P. and Krol,A. (1996) A novel
RNA structural motif in the selenocysteine insertion element of
eukaryotic selenoprotein mRNAs. RNA, 2, 367–379.
5. Grundner-Culemann,E., Martin,G.W.3rd, Harney,J.W. and
Berry,M.J. (1999) Two distinct SECIS structures capable of
directing selenocysteine incorporation in eukaryotes. RNA, 5,
625–635.
6. Fagegaltier,D., Lescure,A., Walczak,R., Carbon,P. and Krol,A.
(2000) Structural analysis of new local features in SECIS RNA
hairpins. Nucleic Acids Res., 28, 2679–2689.
7. Diamond,A., Dudock,B. and Hatﬁeld,D. (1981) Structure and
properties of a bovine liver UGA suppressor serine tRNA with a
tryptophan anticodon. Cell, 25, 497–506.
8. Tujebajeva,R.M., Copeland,P.R., Xu,X.M., Carlson,B.A.,
Harney,J.W., Driscoll,D.M., Hatﬁeld,D.L. and Berry,M.J. (2000)
Decoding apparatus for eukaryotic selenocysteine insertion.
EMBO Rep., 1, 158–163.
9. Fagegaltier,D., Hubert,N., Yamada,K., Mizutani,T., Carbon,P.
and Krol,A. (2000) Characterization of mSelB, a novel
mammalian elongation factor for selenoprotein translation.
EMBO J., 19, 4796–4805.
10. Chavatte,L., Brown,B.A. and Driscoll,D.M. (2005) Ribosomal
protein L30 is a component of the UGA-selenocysteine recoding
machinery in eukaryotes. Nat. Struct. Mol. Biol., 12, 408–416.
11. Copeland,P.R., Fletcher,J.E., Carlson,B.A., Hatﬁeld,D.L. and
Driscoll,D.M. (2000) A novel RNA binding protein, SBP2, is
required for the translation of mammalian selenoprotein mRNAs.
EMBO J., 19, 306–314.
12. Allmang,C., Wurth,L. and Krol,A. (2009) The selenium to
selenoprotein pathway in eukaryotes: More molecular partners
than anticipated. Biochim. Biophys. Acta., 1790, 1415–1423.
13. Donovan,J., Caban,K., Ranaweera,R., Gonzalez-Flores,J.N. and
Copeland,P.R. (2008) A novel protein domain induces high
aﬃnity selenocysteine insertion sequence binding and elongation
factor recruitment. J. Biol. Chem., 283, 35129–35139.
14. Behne,D., Hilmert,H., Scheid,S., Gessner,H. and Elger,W. (1988)
Evidence for speciﬁc selenium target tissues and new biologically
important selenoproteins. Biochim. Biophys. Acta, 966, 12–21.
15. Weiss Sachdev,S. and Sunde,R.A. (2001) Selenium regulation of
transcript abundance and translational eﬃciency of glutathione
peroxidase-1 and -4 in rat liver. Biochem. J., 357, 851–858.
16. Lei,X.G., Evenson,J.K., Thompson,K.M. and Sunde,R.A. (1995)
Glutathione peroxidase and phospholipid hydroperoxide
glutathione peroxidase are diﬀerentially regulated in rats by
dietary selenium. J. Nutr., 125, 1438–1446.
17. Bermano,G., Nicol,F., Dyer,J.A., Sunde,R.A., Beckett,G.J.,
Arthur,J.R. and Hesketh,J.E. (1996) Selenoprotein gene
expression during selenium-repletion of selenium-deﬁcient rats.
Biol. Trace Elem. Res., 51, 211–223.
18. Yant,L.J., Ran,Q., Rao,L., Van Remmen,H., Shibatani,T.,
Belter,J.G., Motta,L., Richardson,A. and Prolla,T.A. (2003) The
selenoprotein GPX4 is essential for mouse development and
protects from radiation and oxidative damage insults.
Free Radic. Biol. Med., 34, 496–502.
4818 Nucleic Acids Research, 2010,Vol.38, No. 1419. Imai,H., Hirao,F., Sakamoto,T., Sekine,K., Mizukura,Y.,
Saito,M., Kitamoto,T., Hayasaka,M., Hanaoka,K. and
Nakagawa,Y. (2003) Early embryonic lethality caused by targeted
disruption of the mouse PHGPx gene. Biochem. Biophys. Res.
Commun., 305, 278–286.
20. Ho,Y.S., Magnenat,J.L., Bronson,R.T., Cao,J., Gargano,M.,
Sugawara,M. and Funk,C.D. (1997) Mice deﬁcient in cellular
glutathione peroxidase develop normally and show no increased
sensitivity to hyperoxia. J. Biol. Chem., 272, 16644–16651.
21. Cheng,W.H., Ho,Y.S., Ross,D.A., Valentine,B.A., Combs,G.F.
and Lei,X.G. (1997) Cellular glutathione peroxidase knockout
mice express normal levels of selenium-dependent plasma and
phospholipid hydroperoxide glutathione peroxidases in various
tissues. J. Nutr., 127, 1445–1450.
22. Squires,J.E., Stoytchev,I., Forry,E.P. and Berry,M.J. (2007) SBP2
binding aﬃnity is a major determinant in diﬀerential
selenoprotein mRNA translation and sensitivity to
nonsense-mediated decay. Mol. Cell Biol., 27, 7848–7855.
23. Bubenik,J.L. and Driscoll,D.M. (2007) Altered RNA binding
activity underlies abnormal thyroid hormone metabolism linked
to a mutation in selenocysteine insertion sequence-binding protein
2. J. Biol. Chem., 282, 34653–34662.
24. Budiman,M.E., Bubenik,J.L., Miniard,A.C., Middleton,L.M.,
Gerber,C.A., Cash,A. and Driscoll,D.M. (2009) Eukaryotic
initiation factor 4a3 is a selenium-regulated RNA-binding protein
that selectively inhibits selenocysteine incorporation. Mol. Cell,
35, 479–489.
25. Lesoon,A., Mehta,A., Singh,R., Chisolm,G.M. and Driscoll,D.M.
(1997) An RNA-binding protein recognizes a mammalian
selenocysteine insertion sequence element required for
cotranslational incorporation of selenocysteine. Mol. Cell Biol.,
17, 1977–1985.
26. Bubenik,J.L., Ladd,A.N., Gerber,C.A., Budiman,M.E. and
Driscoll,D.M. (2009) Known turnover and translation regulatory
RNA-binding proteins interact with the 3’ UTR of
SECIS-binding protein 2. RNA Biol., 6, 73–83.
27. Ray,P.S., Jia,J., Yao,P., Majumder,M., Hatzoglou,M. and
Fox,P.L. (2008) A stress-responsive RNA switch regulates
VEGFA expression. Nature, 457, 915–919.
28. Copeland,P.R. and Driscoll,D.M. (1999) Puriﬁcation, redox
sensitivity, and RNA binding properties of SECIS-binding protein
2, a protein involved in selenoprotein biosynthesis. J. Biol. Chem.,
274, 25447–25454.
29. Gerber,C.A., Relich,A. and Driscoll,D.M. (2004) Isolation of an
mRNA-binding protein involved in C-to-U editing. Methods Mol.
Biol., 265, 239–249.
30. Livak,K.J. and Schmittgen,T.D. (2001) Analysis of relative gene
expression data using real-time quantitative PCR and the 2(-Delta
Delta C(T)) Method. Methods, 25, 402–408.
31. Ginisty,H., Sicard,H., Roger,B. and Bouvet,P. (1999) Structure
and functions of nucleolin. J. Cell Sci., 112(Pt 6), 761–772.
32. Jiang,Y., Xu,X.S. and Russell,J.E. (2006) A nucleolin-binding 30
untranslated region element stabilizes beta-globin mRNA invivo.
Mol. Cell Biol., 26, 2419–2429.
33. Sengupta,T.K., Bandyopadhyay,S., Fernandes,D.J. and
Spicer,E.K. (2004) Identiﬁcation of nucleolin as an AU-rich
element binding protein involved in bcl-2 mRNA stabilization.
J. Biol. Chem., 279, 10855–10863.
34. Singh,K., Laughlin,J., Kosinski,P.A. and Covey,L.R. (2004)
Nucleolin is a second component of the CD154 mRNA stability
complex that regulates mRNA turnover in activated T cells.
J. Immunol., 173, 976–985.
35. Chen,C.Y., Gherzi,R., Andersen,J.S., Gaietta,G., Jurchott,K.,
Royer,H.D., Mann,M. and Karin,M. (2000) Nucleolin and YB-1
are required for JNK-mediated interleukin-2 mRNA stabilization
during T-cell activation. Genes Dev., 14, 1236–1248.
36. Srivastava,M. and Pollard,H.B. (1999) Molecular dissection of
nucleolin’s role in growth and cell proliferation: new insights.
FASEB J., 13, 1911–1922.
37. Zhang,Y., Bhatia,D., Xia,H., Castranova,V., Shi,X. and Chen,F.
(2006) Nucleolin links to arsenic-induced stabilization of
GADD45alpha mRNA. Nucleic Acids Res., 34, 485–495.
38. Fahling,M., Steege,A., Perlewitz,A., Nafz,B., Mrowka,R.,
Persson,P.B. and Thiele,B.J. (2005) Role of nucleolin in
posttranscriptional control of MMP-9 expression. Biochim.
Biophys. Acta, 1731, 32–40.
39. Wu,R., Shen,Q. and Newburger,P.E. (2000) Recognition and
binding of the human selenocysteine insertion sequence by
nucleolin. J. Cell Biochem., 77, 507–516.
40. Mili,S. and Steitz,J.A. (2004) Evidence for reassociation of
RNA-binding proteins after cell lysis: implications for the
interpretation of immunoprecipitation analyses. RNA, 10,
1692–1694.
41. Clery,A., Blatter,M. and Allain,F.H. (2008) RNA recognition
motifs: boring? Not quite. Curr. Opin. Struct. Biol., 18, 290–298.
42. Maris,C., Dominguez,C. and Allain,F.H. (2005) The RNA
recognition motif, a plastic RNA-binding platform to regulate
post-transcriptional gene expression. FEBS J., 272, 2118–2131.
43. Ghisolﬁ-Nieto,L., Joseph,G., Puvion-Dutilleul,F., Amalric,F. and
Bouvet,P. (1996) Nucleolin is a sequence-speciﬁc RNA-binding
protein: characterization of targets on pre-ribosomal RNA.
J. Mol. Biol., 260, 34–53.
44. Serin,G., Joseph,G., Faucher,C., Ghisolﬁ,L., Bouche,G.,
Amalric,F. and Bouvet,P. (1996) Localization of nucleolin binding
sites on human and mouse pre-ribosomal RNA. Biochimie, 78,
530–538.
45. Bouvet,P., Jain,C., Belasco,J.G., Amalric,F. and Erard,M. (1997)
RNA recognition by the joint action of two nucleolin
RNA-binding domains: genetic analysis and structural modeling.
EMBO J., 16, 5235–5246.
46. Ginisty,H., Amalric,F. and Bouvet,P. (2001) Two diﬀerent
combinations of RNA-binding domains determine the RNA
binding speciﬁcity of nucleolin. J. Biol. Chem., 276, 14338–14343.
47. Zhang,J., Tsaprailis,G. and Bowden,G.T. (2008) Nucleolin
stabilizes Bcl-X L messenger RNA in response to UVA
irradiation. Cancer Res., 68, 1046–1054.
48. Fahling,M., Mrowka,R., Steege,A., Nebrich,G., Perlewitz,A.,
Persson,P.B. and Thiele,B.J. (2006) Translational control of
collagen prolyl 4-hydroxylase-alpha(I) gene expression under
hypoxia. J. Biol. Chem., 281, 26089–26101.
49. Carlson,B.A., Xu,X.M., Gladyshev,V.N. and Hatﬁeld,D.L. (2005)
Selective rescue of selenoprotein expression in mice lacking a
highly specialized methyl group in selenocysteine tRNA.
J. Biol. Chem., 280, 5542–5548.
50. Howard,M.T., Aggarwal,G., Anderson,C.B., Khatri,S.,
Flanigan,K.M. and Atkins,J.F. (2005) Recoding elements located
adjacent to a subset of eukaryal selenocysteine-specifying UGA
codons. EMBO J., 24, 1596–1607.
51. Sunde,R.A. (2001) In Hatﬁeld,D.L. (ed.), Selenium: Its Molecular
Biology and Role in Human Health. Kluwer Academic Publishers,
Norwell, MA, pp. 81–98.
52. Jeong,D.W., Kim,E.H., Kim,T.S., Chung,Y.W., Kim,H. and
Kim,I.Y. (2004) Diﬀerent distributions of selenoprotein W and
thioredoxin during postnatal brain development and
embryogenesis. Mol. Cells, 17, 156–159.
53. Lescure,A., Rederstorﬀ,M., Krol,A., Guicheney,P. and
Allamand,V. (2009) Selenoprotein function and muscle disease.
Biochim. Biophys. Acta, 1790, 1569–1574.
54. Kohrle,J. (2005) Selenium and the control of thyroid hormone
metabolism. Thyroid, 15, 841–853.
55. Wingler,K., Bocher,M., Flohe,L., Kollmus,H. and Brigelius-
Flohe,R. (1999) mRNA stability and selenocysteine insertion
sequence eﬃciency rank gastrointestinal glutathione peroxidase
high in the hierarchy of selenoproteins. Eur. J. Biochem., 259,
149–157.
56. Schneider,M.J., Fiering,S.N., Pallud,S.E., Parlow,A.F., St
Germain,D.L. and Galton,V.A. (2001) Targeted disruption of the
type 2 selenodeiodinase gene (DIO2) results in a phenotype of
pituitary resistance to T4. Mol. Endocrinol., 15, 2137–2148.
57. Schneider,M.J., Fiering,S.N., Thai,B., Wu,S.Y., St Germain,E.,
Parlow,A.F., St Germain,D.L. and Galton,V.A. (2006) Targeted
disruption of the type 1 selenodeiodinase gene (Dio1) results in
marked changes in thyroid hormone economy in mice.
Endocrinology, 147, 580–589.
58. Esworthy,R.S., Aranda,R., Martin,M.G., Doroshow,J.H.,
Binder,S.W. and Chu,F.F. (2001) Mice with combined disruption
of Gpx1 and Gpx2 genes have colitis. Am. J. Physiol.
Gastrointest. Liver Physiol., 281, G848–G855.
Nucleic Acids Research, 2010,Vol.38, No. 14 481959. Fomenko,D.E., Novoselov,S.V., Natarajan,S.K., Lee,B.C.,
Koc,A., Carlson,B.A., Lee,T.H., Kim,H.Y., Hatﬁeld,D.L. and
Gladyshev,V.N. (2009) MsrB1 (methionine-R-sulfoxide reductase
1) knock-out mice: roles of MsrB1 in redox regulation and
identiﬁcation of a novel selenoprotein form. J. Biol. Chem., 284,
5986–5993.
60. Yang,C., Maiguel,D.A. and Carrier,F. (2002) Identiﬁcation of
nucleolin and nucleophosmin as genotoxic stress-responsive
RNA-binding proteins. Nucleic Acids Res., 30, 2251–2260.
61. Daniely,Y. and Borowiec,J.A. (2000) Formation of a complex
between nucleolin and replication protein A after cell stress prevents
initiation of DNA replication. J. Cell Biol., 149, 799–810.
62. Hanakahi,L.A., Bu,Z. and Maizels,N. (2000) The C-terminal
domain of nucleolin accelerates nucleic acid annealing.
Biochemistry, 39, 15493–15499.
63. Bouvet,P., Diaz,J.J., Kindbeiter,K., Madjar,J.J. and Amalric,F.
(1998) Nucleolin interacts with several ribosomal proteins through
its RGG domain. J. Biol. Chem., 273, 19025–19029.
64. Barel,M., Hovanessian,A.G., Meibom,K., Briand,J.P., Dupuis,M.
and Charbit,A. (2008) A novel receptor - ligand pathway for
entry of Francisella tularensis in monocyte-like THP-1 cells:
interaction between surface nucleolin and bacterial elongation
factor Tu. BMC Microbiol., 8, 145.
4820 Nucleic Acids Research, 2010,Vol.38, No. 14